The funding will help push the boundaries of AI-driven patient monitoring, empowering healthcare professionals with predictive tools that eliminate uncertainty and enable confident decision-making

Lifesigns, a pioneer in intelligent patient monitoring solutions, has secured funding from Healthcare Capital, the investment arm of the Kauvery Hospital Group.

The investment will primarily advance Lifesigns’ AI and predictive algorithm capabilities, further enhancing its proprietary patient monitoring platform. Lifesigns remains the only solution offering USFDA-approved hardware, software, dashboard, and AI integration, delivering proactive alerts and predictive insights across the patient journey—from ambulances to hospitals and home care. 

“Our journey with Kauvery Hospital has been more than just a customer relationship—it has been an innovation partnership. This investment from Healthcare Capital is a testament to the trust they place in our technology and its impact on healthcare outcomes,” said Hari Subramaniam, Founder and CEO, Lifesigns. “With this funding, we aim to push the boundaries of AI-driven patient monitoring, empowering healthcare professionals with predictive tools that eliminate uncertainty and enable confident decision-making.” 

Dr Aravindan Selvaraj, Executive Director, Kauvery Hospital and Healthcare Capital said, "Lifesigns’ technology is a game-changer, and we are excited to support their mission in redefining patient monitoring with AI-powered predictive analytics.” 

While Lifesigns continues to focus on AI advancements, the company is also gearing up for its next funding round in the next couple of months, where it plans to unveil new tech products and market expansion initiatives. With this strategic investment, Lifesigns is set to accelerate innovation, solidify its position as a leader in health tech, and contribute to shaping the future of patient monitoring.